{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:50:31Z","timestamp":1794293431931,"version":"4.9.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Basic Research Program of Shanxi Province (Natural Science General Project)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03238-5","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:06:13Z","timestamp":1781085973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of the C-reactive protein-triglyceride-glucose (CTI) index and its central obesity-modified derivatives with incident cardiometabolic multimorbidity: results from two prospective cohorts in China and England"],"prefix":"10.1186","volume":"25","author":[{"given":"Chuhui","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaona","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"1","key":"3238_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"6","key":"3238_CR2","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-7568(23)00054-5","volume":"4","author":"Y Jin","year":"2023","unstructured":"Jin Y, Liang J, Hong C, Liang R, Luo Y. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study. Lancet Healthy Longev. 2023;4(6):e265\u201373.","journal-title":"Lancet Healthy Longev"},{"issue":"7","key":"3238_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurheartj\/ehac744","volume":"44","author":"A Dove","year":"2023","unstructured":"Dove A, Guo J, Marseglia A, Fastbom J, Vetrano DL, Fratiglioni L, et al. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry. Eur Heart J. 2023;44(7):573\u201382.","journal-title":"Eur Heart J"},{"issue":"3","key":"3238_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.","journal-title":"BMJ Open"},{"issue":"1","key":"3238_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/gh.1188","volume":"18","author":"P Otieno","year":"2023","unstructured":"Otieno P, Asiki G, Aheto JMK, Wilunda C, Sanya RE, Wami W, et al. Cardiometabolic multimorbidity associated with moderate and severe disabilities: results from the study on global AGEing and adult health (SAGE) wave 2 in Ghana and South Africa. Glob Heart. 2023;18(1):9.","journal-title":"Glob Heart"},{"issue":"3","key":"3238_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/alz.12708","volume":"19","author":"A Dove","year":"2023","unstructured":"Dove A, Marseglia A, Shang Y, Grande G, Vetrano DL, Laukka EJ, et al. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression. Alzheimers Dement. 2023;19(3):821\u201330.","journal-title":"Alzheimers Dement"},{"issue":"25","key":"3238_CR7","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3238_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/s41591-020-0786-7","volume":"26","author":"N Sattar","year":"2020","unstructured":"Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26(3):320\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"3238_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-025-03067-y","volume":"25","author":"H Lai","year":"2026","unstructured":"Lai H, Deng C, Liao C, Tian R, Liu K, Luo Z, et al. Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011\u20132020). Cardiovasc Diabetol. 2026;25(1):37.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3238_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41574-025-01114-y","volume":"21","author":"D Accili","year":"2025","unstructured":"Accili D, Deng Z, Liu Q. Insulin resistance in type 2 diabetes mellitus. Nat Rev Endocrinol. 2025;21(7):413\u201326.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"3238_CR11","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-223.","journal-title":"Am J Physiol"},{"issue":"7","key":"3238_CR12","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3238_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/bc.bc_32_24","volume":"11","author":"J Li","year":"2025","unstructured":"Li J, Zhao S, Zhang X, Fan M, Wan J, Lin R, et al. Association of systemic inflammatory response index with the cardiometabolic multimorbidity among us adults: a population-based study. Brain Circ. 2025;11(1):39\u201347.","journal-title":"Brain Circ"},{"issue":"1","key":"3238_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02939-7","volume":"24","author":"X Ruan","year":"2025","unstructured":"Ruan X, Ling Y, Chen J, Xiang Y, Ruan H, Zhang W, et al. Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):382.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3238_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148556","volume":"132","author":"NE Boutagy","year":"2022","unstructured":"Boutagy NE, Singh AK, Sessa WC. Targeting the vasculature in cardiometabolic disease. J Clin Invest. 2022;132(6):e148556.","journal-title":"J Clin Invest"},{"key":"3238_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol (Lausanne). 2022;13:905266.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3238_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-025-03870-7","volume":"25","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Lin H, Weng X, Dai H, Xu J. Correlation between hs-CRP-triglyceride glucose index and NAFLD and liver fibrosis. BMC Gastroenterol. 2025;25(1):252.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"3238_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, et al. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01947-8","volume":"25","author":"Y Shan","year":"2025","unstructured":"Shan Y, Liu Q, Gao T. Application of the C-reactive protein-triglyceride glucose index in predicting the risk of new-onset diabetes in the general population aged 45 years and older: a national prospective cohort study. BMC Endocr Disord. 2025;25(1):126.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"3238_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-026-03174-4","volume":"25","author":"L Yuan","year":"2026","unstructured":"Yuan L, Zhao Z, Peng H, Zong W, Zhu J, Qu H, et al. Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study. Cardiovasc Diabetol. 2026;25(1):125.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3238_CR22","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM. Metabolic inflammation and insulin resistance in obesity. Circ Res. 2020;126(11):1549\u201364.","journal-title":"Circ Res"},{"key":"3238_CR23","volume":"28","author":"L Zhang","year":"2026","unstructured":"Zhang L, Yan M, Hu C, Tao Y, Cheng Z, Zhang Y, et al. Association between body roundness index trajectories and the risk of cardiometabolic multimorbidity in Chinese middle-aged and older adults: Evidence from the China health and retirement longitudinal study. Int J Cardiol Cardiovasc Risk Prev. 2026;28:200556.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"1","key":"3238_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13690-025-01762-6","volume":"83","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H, Liu X, Zhang J. Improving cardiometabolic multimorbidity prediction with a composite obesity-TyG index: a study of middle-aged and older adults in CHARLS. Arch Public Health. 2025;83(1):271.","journal-title":"Arch Public Health"},{"key":"3238_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000984","author":"S Shetty","year":"2025","unstructured":"Shetty S, Suvarna R, Bhattacharya S, Seetharaman K. Visceral adiposity and cardiometabolic risk: clinical insights and assessment. Cardiol Rev. 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000000984.","journal-title":"Cardiol Rev"},{"issue":"1","key":"3238_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12933-025-02921-3","volume":"24","author":"M Chen","year":"2025","unstructured":"Chen M, Guo J, Shangguan Y, Sun Z, He X, Tu Q, et al. Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0\u20133: findings from two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):366.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12916-025-04175-y","volume":"23","author":"X He","year":"2025","unstructured":"He X, Li C, Hua G, Wang Y, Zhang L, Cheng C, et al. Cross-national differences in the association between estimated cardiorespiratory fitness and depressive symptoms among older adults: findings from three nationwide cohort studies. BMC Med. 2025;23(1):363.","journal-title":"BMC Med"},{"issue":"1","key":"3238_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3238_CR30","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/ije\/dys168","volume":"42","author":"A Steptoe","year":"2013","unstructured":"Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. 2013;42(6):1640\u20138.","journal-title":"Int J Epidemiol"},{"key":"3238_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111894","volume":"217","author":"Q Xu","year":"2024","unstructured":"Xu Q, Tian X, Xia X, Zhang Y, Zheng M, Wang A. Estimated glucose disposal rate, high sensitivity C-reactive protein and cardiometabolic multimorbidity in middle-aged and older Chinese adults: A nationwide prospective cohort study. Diabetes Res Clin Pract. 2024;217:111894.","journal-title":"Diabetes Res Clin Pract"},{"key":"3238_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1511319","volume":"16","author":"B Wan","year":"2025","unstructured":"Wan B, Wang S, Hu S, Han W, Qiu S, Zhu L, et al. The comprehensive effects of high-sensitivity C-reactive protein and triglyceride glucose index on cardiometabolic multimorbidity. Front Endocrinol (Lausanne). 2025;16:1511319.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3238_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02869-4","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, Ma X, Wang Y, Qiu G, Zhang C. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):303.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12933-026-03109-z","volume":"25","author":"Y Lin","year":"2026","unstructured":"Lin Y, Tao J, Wang H, Guan H, Liu X, Dong X, et al. The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Cardiovasc Diabetol. 2026;25(1):90.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-026-03151-x","volume":"25","author":"J Du","year":"2026","unstructured":"Du J, Man Z, Bai X, Luo D, Guo Q, Wang Y, et al. Association of C-reactive protein-triglycerides-glucose index-waist to height ratio and cardiometabolic multimorbidity in middle-aged and older adults: a nationwide cohort study. Cardiovasc Diabetol. 2026;25(1):122.","journal-title":"Cardiovasc Diabetol"},{"key":"3238_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03181-5","author":"X Li","year":"2026","unstructured":"Li X, Meng Y, Zhang L, Li T, Yan G. Metabolic status modifies the predictive value of the C-reactive protein-triglyceride-glucose Index-waist-to-height ratio for major adverse cardiovascular and cerebrovascular events: a prospective cohort study from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03181-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-026-03168-2","volume":"25","author":"J Lai","year":"2026","unstructured":"Lai J, Liu Z, Wang H, Kong X, Wei Y, Cao Y. Assessment of seven insulin resistance surrogate indexes for predicting cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study. Cardiovasc Diabetol. 2026;25(1):121.","journal-title":"Cardiovasc Diabetol"},{"key":"3238_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03154-8","author":"S Ma","year":"2026","unstructured":"Ma S, Jiang M, Xuan Y, Shen Y, Chen K, Li B. Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03154-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"17","key":"3238_CR39","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1093\/eurjpc\/zwac187","volume":"29","author":"F Lopez-Jimenez","year":"2022","unstructured":"Lopez-Jimenez F, Almahmeed W, Bays H, Cuevas A, Di Angelantonio E, le Roux CW, et al. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. Eur J Prev Cardiol. 2022;29(17):2218\u201337.","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"3238_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301\u201313.","journal-title":"Circulation"},{"issue":"1","key":"3238_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrendo.2015.189","volume":"12","author":"DE Lackey","year":"2016","unstructured":"Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016;12(1):15\u201328.","journal-title":"Nat Rev Endocrinol"},{"issue":"6652","key":"3238_CR42","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.abn1725","volume":"380","author":"T Zhang","year":"2023","unstructured":"Zhang T, Xu D, Trefts E, Lv M, Inuzuka H, Song G, et al. Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. Science. 2023;380(6652):1372\u201380.","journal-title":"Science"},{"issue":"2","key":"3238_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s42255-024-00978-0","volume":"6","author":"W Xia","year":"2024","unstructured":"Xia W, Veeragandham P, Cao Y, Xu Y, Rhyne TE, Qian J, et al. Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. Nat Metab. 2024;6(2):273\u201389.","journal-title":"Nat Metab"},{"issue":"3","key":"3238_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/STROKEAHA.122.039542","volume":"54","author":"A Jin","year":"2023","unstructured":"Jin A, Wang S, Li J, Wang M, Lin J, Li H, et al. Mediation of systemic inflammation on insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Stroke. 2023;54(3):759\u201369.","journal-title":"Stroke"},{"issue":"1","key":"3238_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02159-5","volume":"23","author":"T Yang","year":"2024","unstructured":"Yang T, Li G, Wang C, Xu G, Li Q, Yang Y, et al. Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study. Cardiovasc Diabetol. 2024;23(1):79.","journal-title":"Cardiovasc Diabetol"},{"issue":"30","key":"3238_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303259","volume":"10","author":"SM Andrabi","year":"2023","unstructured":"Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, et al. Nitric oxide: physiological functions, delivery, and biomedical applications. Adv Sci (Weinh). 2023;10(30):e2303259.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3238_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02244-9","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z, et al. Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort study. Cardiovasc Diabetol. 2024;23(1):156.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40021-6","volume":"14","author":"JE Toller-Kawahisa","year":"2023","unstructured":"Toller-Kawahisa JE, Hiroki CH, Silva CMS, Nascimento DC, P\u00fablio GA, Martins TV, et al. The metabolic function of pyruvate kinase M2 regulates reactive oxygen species production and microbial killing by neutrophils. Nat Commun. 2023;14(1):4280.","journal-title":"Nat Commun"},{"issue":"1","key":"3238_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","volume":"20","author":"SI Bloom","year":"2023","unstructured":"Bloom SI, Islam MT, Lesniewski LA, Donato AJ. Mechanisms and consequences of endothelial cell senescence. Nat Rev Cardiol. 2023;20(1):38\u201351.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"3238_CR50","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.immuni.2025.07.012","volume":"58","author":"SE Weinberg","year":"2025","unstructured":"Weinberg SE, Chandel NS. Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells. Immunity. 2025;58(8):1904\u201321.","journal-title":"Immunity"},{"issue":"11","key":"3238_CR51","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","volume":"22","author":"DE James","year":"2021","unstructured":"James DE, St\u00f6ckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3238_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02724-6","volume":"24","author":"B Wang","year":"2025","unstructured":"Wang B, Li L, Tang Y, Ran X. Joint association of triglyceride glucose index (TyG) and body roundness index (BRI) with stroke incidence: a national cohort study. Cardiovasc Diabetol. 2025;24(1):164.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12933-024-02278-z","volume":"23","author":"C Cui","year":"2024","unstructured":"Cui C, Qi Y, Song J, Shang X, Han T, Han N, et al. Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults. Cardiovasc Diabetol. 2024;23(1):185.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3238_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, et al. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313.","journal-title":"Cardiovasc Diabetol"},{"key":"3238_CR56","unstructured":"Collaboration NCDRF. General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7.5 million participants. Lancet. 2024; 404(10455):851-863."},{"issue":"6","key":"3238_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/genes12060841","volume":"12","author":"C Sun","year":"2021","unstructured":"Sun C, Kovacs P, Guiu-Jurado E. Genetics of body fat distribution: comparative analyses in populations with European, Asian and African Ancestries. Genes (Basel). 2021;12(6):841.","journal-title":"Genes (Basel)"},{"issue":"9921","key":"3238_CR58","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(13)61836-X","volume":"383","author":"Y Lu","year":"2014","unstructured":"Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1\u00b78 million participants. Lancet. 2014;383(9921):970\u201383.","journal-title":"Lancet"},{"issue":"4","key":"3238_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006633","volume":"5","author":"X Yuan","year":"2015","unstructured":"Yuan X, Liu T, Wu L, Zou ZY, Li C. Validity of self-reported diabetes among middle-aged and older Chinese adults: the China Health and Retirement Longitudinal Study. BMJ Open. 2015;5(4):e006633.","journal-title":"BMJ Open"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03238-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03238-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T22:32:43Z","timestamp":1786919563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03238-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3238"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03238-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9222050\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ELSA and the CHARLS were approved by the London Multicentre Research Ethics Committee and the Peking University Institutional Review Board, respectively. All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"233"}}